Furthermore, Remodelin combined with anti–PD-1 treatment substantially increased the infiltration of CD8+ T cells into the tumor (Figure 9B), accompanied by a high percentage of GzmB+ and IFN-γ+ CD8+ T cells (Figure 9C), demonstrating that NAT10 inhibition enhances the effects of PD-1 blockade. Here, CD8A is linked to neoplasm.